Stay updated on Anifrolumab SubQ in Lupus Adults Clinical Trial
Sign up to get notified when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.

Latest updates to the Anifrolumab SubQ in Lupus Adults Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as numerous updates to study statuses and contact information. However, several location-related terms and details have been removed.SummaryDifference39%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has updated its version from v2.16.11 to v2.16.12 and changed the date from 2025-07-11 to 2025-08-12.SummaryDifference1.0%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check30 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check37 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check44 days agoChange DetectedThe web page has been updated to reflect a new version release, moving from v2.16.5 to v2.16.6, and the date has been changed from June 10, 2025, to July 11, 2025.SummaryDifference1.0%
Stay in the know with updates to Anifrolumab SubQ in Lupus Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.